Syndemics of chronic and acute diseases in vulnerable populations

  • chrysanthus Chukwuma sr centre for future-oriented studies
Keywords: Co-morbidity, Diabetes, Infectious, Non-communicable, Obesity, Syndemics, Reemerging

Abstract

This study portends to develop and improve the welfare and well-being of vulnerable populations in the interactions or co-morbidities or co-occurrence  of re-emerging infectious diseases, obesity, diabetes or metabolic syndrome in contextually, socioeconomic milieu; provide newfangled healthcare research modalities and techniques to vulnerable populations globally; develop and promote evidence-based strategies to mitigate or eradicate health development challenges via inter alia providing innovative research funding to curb inequitable gender norms, perceived internalized stigma, validate a measure of rights-based access to healthcare in co-occurrence of acute and chronic diseases with minimal costs or prices within the spectrum of vulnerable populations. Regarding socioeconomic status and income as facilitator, it is pertinent that public health and national economy modify the allocation of healthcare expenditures to presenting social programmes. One major constraint is that a vast majority of the data on the epidemiology of the interface between chronic and acute disorders with undergirding socioeconomic factors emerge from developed countries, whereas the population at risk are in LMICs.

Downloads

Download data is not yet available.

Author Biography

chrysanthus Chukwuma sr, centre for future-oriented studies

Executive Director, Dept of Futures Studies

References


Candib LM. Obesity and diabetes in vulnerable populations: Reflections on proximal and distal causes. Ann Fam Med, 2007; 5(6): 547-556.

Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D. Non-communicable disease syndemics: Poverty, depression, and diabetes among low-income populations. The Lancet, 2017; 389 (10072): 951-963

Peter N. The converging burdens of infectious and non-communicable diseases in rural-to-urban migrant sub-Saharan African populations: a focus on HIV/AIDS, tuberculosis and cardiometabolic diseases. Tropical Diseases, Travel Medicine and Vaccines, 2015; 1:6).

Ayibode A. 2017. Like Ebola, like Meningitis: The sad story of Africa’s vulnerability to deadly and infectious diseases. https://www.naij.com/1098124-like-ebola-meningitis-the-sad-story-africas-vulnerability-deadly-infections.html.

Chukwuma Sr C. 2015. Paradigm for implementing sustainable modalities against the emergence and re-emergence of parasitoses and infectious diseases. Applied Science Reports, 2015; 9(3):129-138. DOI: 10.15192/PSCP.ASR.2015.9.3.129138.

Institute of Medicine (US) Forum on Microbial Threats. 2004. Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary. Knobler S, Mahmoud A, Lemon S, et al., editors. Washington, DC, National Academies Press, US.

National Research Council. 2011. Explaining divergent levels of longevity in high-income countries. The National Academies Collection. Report funded by National Institutes of Health, Washington, DC: National Academic Press (US).

Finncane MM, Stevens GA, Cowan MJ, Danaei G et al. National, regional and global trends in body-mass index since 1980: Systemic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. The Lancet 2011; 377: 557-567.

Ng M, Freeman MK, Fleming TD, Robinson M et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA, 2014; 311: 183-192 http://doi.org/10.1001/jama.2013.284692 .

Martikainen P, Ho JY, Preston S, Elo IT. The changing contribution of smoking to educational differences in life expectancy: indirect estimates for Finnish men and women from 1971 to 2010. J Epidemiol & Community Health, 2013; 67: 219-224.

Mehta NK, House JS, Elliott MR. Dynamics of health behavior and socioeconomic differences in mortality in the USA. J Epidemiol & Community Health, 2015; 69: 416-422.

Mehta N, Elo I, Stenholm S, Aromaa A, Heliovaara M, Koskinen S. International differences in the risk of death from smoking and obesity: The case of the United States and Finland. SSM – Population Health, 2016; 3: 141-152.

Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain et al. Predicting diabetes: clinical, biological, and genetic approaches: Data from the epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care, 2008; 31: 2056-2061.

Kahn HS, Cheng YJ, Thompson TJ, Imperatore G and Gregg EW. Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years. Ann Intern Med, 22009; 150: 741-751.

Pollock BD, Hu T, Chen W, Harville EW, Li S, Webber LS, Fonseca V, Bazzano LA. Utility of existing diabetes risk prediction tools for young black and white adults. Evidence from the Bogalusa Heart Study. J Diab Complications, 2017; 31(1): 86-93.

Falagas MA and Kompoti M. Obesity and infection. The Lancet, 2006; 6(7): 438-446.

Langley G, Hao Y, Pondo T, Miller L, Petit S, Thomas A et al. The impact of obesity and diabetes on the risk of disease and death due to invasive group A Streptococcus infections in adults. Clin Infect Dis, 2016; 62(7): 845-852.

Hopkins SE, Austin MA, Metzger JS, Koller KR, Umans JC et al. Sex differences in obesity prevalence and cardiometabolic factors among Western Alaska Native people. Nutr Metab Cardio Dis, 2015; 25(3): 312-318.

Risica PM, Schraer C, Ebbesson SO, Nobmann ED and Caballero B. Overweight and obesity among Alaskan Eskimos of the Bering Straits region: the Alaska Siberia project. Int J Obes Relat Metab Disord, 2000; 24: 939-944.

Bjerregard P, Jorgensen ME, Andersen S, Mulvad G, Borch-Johnsen K. Decreasing overweight and central fat patterning with westernization among the Inuit in Greenland and Inuit migrants. Int J Obes Relat Metab Disord, 2002; 26: 1503-1510.

Lopez L, Tan-McGrory A, Horner G, Betancourt JR. Eliminating disparities among Latinos with type 2 diabetes: Effective eHealth strategies. J Diab Complications, 2016; 30(3):554-560 doi:http//dx.doi.org/10.1016/jdiacomp.2015.12.003.

Horton R. 2013. Non-communicable diseases: 2015 to 2025. Lancet, 381: 509-510.

Huttunen R and Syrjanen J. Obesity and the risk and outcome of infection. Int J Obes, 2013; 37: 333-340 doi:10.1038/ijo.2012.62.

Fischer-Hoch SP, Mathews CE, McCormick JB. Obesity, diabetes and pneumonia: the menacing interface of non-communicable and infectious diseases. Tropical Medicine & International Health, 2013; 18(12): 1510-1519.
Article Information
Received: 2017-07-01
Published: 2017-09-13

Issue: Vol 4 No 1 (2017): AMS

Section: Review Articles

Pages: 01-03
How to Cite
1.
Chukwuma sr chrysanthus. Syndemics of chronic and acute diseases in vulnerable populations. Acta Medica Scientia [Internet]. 13Sep.2017 [cited 14Dec.2017];4(1):01-3. Available from: http://asdpub.com/index.php/ams/article/view/360